...
首页> 外文期刊>Pakistan Heart Journal >ROLE OF IMAGING TECHNOLOGY AND CURRENT STATUS OF CORONAVIRUS DISEASE 2019 (COVID-19): A CRITICAL REVIEW
【24h】

ROLE OF IMAGING TECHNOLOGY AND CURRENT STATUS OF CORONAVIRUS DISEASE 2019 (COVID-19): A CRITICAL REVIEW

机译:2019(Covid-19)的成像技术和现状的成像技术和现状:批判性审查

获取原文
           

摘要

Lately, there was an outbreak of Coronavirus disease (COVID-19) in Wuhan, a city of province Hubei, China. The infectious and transferrable virus originated in bats, seafood and animals. COVID-19 belongs to Coronviradae family. Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) also belong to this family and their outbreak occurred in China and Saudi Arabia back in 2003 and 2012. number of deaths due to COVID-19 is much greater than that of SARS and MERS. The he clinical symptoms of infected individuals from virus are almost the same but diagnostically they are different from one another. Reverse transcription polymerase chain reaction (RT-PCR) laboratory technique is a standard test for evaluation and confirmation of COVID-19 disease. In early stages, imaging modalities can be used for screening purposes. X-Ray is used to identify the gross changes within the chest region while Computed Tomography Scanning (CT Scan) chest is used for detailed modification which occurs due to coronavirus. CT scan evaluates the different characteristics in the individuals infected from COVID-19 such as presence of bilateral ground glass opacities, presence of diffuse consolidation, presence of nodules with halo sign, enlarge thoracic lymph nodes, presence of thicken inter-lobar septa, presence of bronchiectasis and pleural effusion. Each lung lobe was assigned different score on the basis of lobe area involvement. A lobe having no involvement is of score 0, minimal involvement lobe score is 1, mild involvement lobe score is 2, moderate involvement lobe score is 3, and severe involvement lobe score is 4. The lobes are assessed for different degree of involvement and then are divided as none (0%), minimal (1% to 25%), mild (26% to 50%), moderate (51% to 75%) and severe 76% to above level. These all techniques are very effective and responsible for the exact location of the area involved and also show the extension of pathology that can only be possible on CT scan. CT scan not only evaluates the disease but it also provides the assessment of the disease severity.
机译:最近,武汉武汉冠心病(Covid-19)爆发了中国,中国湖北省。传染病和可转移的病毒起源于蝙蝠,海鲜和动物。 Covid-19属于Coronviradae家族。严重的急性呼吸综合征(SARS)和中东呼吸综合征(MERS)也属于这个家庭,他们在2003年和2012年的中国和沙特阿拉伯发生了爆发。Covid-19因SARS而导致的死亡人数远远大于SARS和mers。来自病毒感染个体的临床症状几乎相同,但诊断地彼此不同。逆转录聚合酶链反应(RT-PCR)实验室技术是评估和确认Covid-19疾病的标准测试。在早期阶段,成像模式可用于筛选目的。 X射线用于识别胸部区域内的总变化,而计算机断层摄影扫描(CT扫描)胸部用于由于冠状病毒而发生的详细修改。 CT扫描评估从Covid-19感染的个体中的不同特征,例如双侧覆盖玻璃不透明度,弥漫性固结的存在,具有晕符号的结节存在,扩大胸淋巴结,增稠间隔内隔膜的存在,存在支气管扩张和胸腔积液。每个肺叶在叶片区域参与的基础上被分配不同的分数。没有参与的叶片是0分,最小的受累叶片评分为1,温和的受累叶评数为2,中度受累叶片评分为3,严重的受累叶评数为4.裂片被评估为不同程度的参与程度分为无(0%),最小(1%至25%),轻度(26%至50%),中等(51%至75%),严重76%至上方。这些所有技术都非常有效,并对所涉及的区域的确切位置负责,并且还显示出可在CT扫描上才能进行病理学的扩展。 CT扫描不仅评估疾病,而且还提供了对疾病严重程度的评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号